BioSpace News Archive

Press Releases

FDA approves Novo Nordisk’s Sogroya® as the first and only once-weekly, long-acting growth hormone for three additional pediatric indications

March 2, 2026
·
13 min read
Press Releases

FDA Approves Once-Weekly YUVIWEL® (navepegritide) for Children with Achondroplasia Aged 2 Years and Older

March 2, 2026
·
11 min read
Press Releases

Femasys Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 27, 2026

March 2, 2026
·
4 min read
Press Releases

XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing

March 2, 2026
·
4 min read
Press Releases

Prothena Announces up to $100 Million Share Repurchase Plan

March 2, 2026
·
3 min read
Press Releases

Novocure to Participate in 2026 Leerink Global Healthcare Conference

March 2, 2026
·
2 min read
Press Releases

Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE034

March 2, 2026
·
3 min read
Press Releases

FCS Foundation Marks Rare Disease Day to Elevate Awareness and Support for Families Living with Familial Chylomicronemia Syndrome

March 2, 2026
·
1 min read
Press Releases

CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 2, 2026
·
1 min read
Press Releases

KEYTRUDA® (pembrolizumab) Plus WELIREG® (belzutifan) Given as Adjuvant Therapy Reduced the Risk of Disease Recurrence or Death by 28% Compared to KEYTRUDA Monotherapy in Certain Patients With Earlier-Stage Renal Cell Carcinoma (RCC)

March 2, 2026
·
19 min read